Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Tax Provisions (2016 - 2018)

China Pharma Holdings (CPHI) has disclosed Tax Provisions for 9 consecutive years, with $71535.0 as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Tax Provisions rose 134.35% year-over-year to $71535.0, compared with a TTM value of -$40375.0 through Dec 2018, down 132.92%, and an annual FY2018 reading of -$109989.0, down 189.69% over the prior year.
  • Tax Provisions was $71535.0 for Q4 2018 at China Pharma Holdings, up from -$160485.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $243131.0 in Q4 2016 and bottomed at -$160485.0 in Q3 2018.
  • Average Tax Provisions over 5 years is $9283.7, with a median of -$10863.5 recorded in 2015.
  • The sharpest move saw Tax Provisions skyrocketed 8718.61% in 2016, then crashed 614.41% in 2018.
  • Year by year, Tax Provisions stood at -$19284.0 in 2014, then skyrocketed by 85.37% to -$2821.0 in 2015, then surged by 8718.61% to $243131.0 in 2016, then plummeted by 87.45% to $30525.0 in 2017, then skyrocketed by 134.35% to $71535.0 in 2018.
  • Business Quant data shows Tax Provisions for CPHI at $71535.0 in Q4 2018, -$160485.0 in Q3 2018, and $22590.0 in Q2 2018.